Education
About Us
Working with TipRanks
Follow Us
biote (BTMD)
NASDAQ:BTMD
Earnings Data
Report Date
May 13, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.08Last Year’s EPS
-0.06Same Quarter Last Year
Strong Buy
Based on 6 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 12, 2025
|% Change Since: -11.46%
|Next Earnings Date:May 13, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted several positive aspects, such as revenue growth, improved gross profit margins, and successful integration of acquisitions. However, these were countered by notable challenges, including a decline in net income, slowed new customer growth, increased SG&A expenses, and modest procedural revenue growth expectations. The balance of positive and negative elements results in a neutral sentiment.Company Guidance
During the Biote Fourth Quarter 2024 Earnings Conference Call, financial guidance for 2025 was provided with several key metrics. The company anticipates revenue between $202 million and $208 million and adjusted EBITDA ranging from $59 million to $64 million. Procedure revenue is projected to grow by approximately 2% to 4%, while dietary supplement revenue is expected to see an increase of 5% to 10% from 2024 levels. For the first quarter of 2025, Biote forecasts a slight increase in revenue compared to the first quarter of 2024, despite an expected 5% decline in adjusted EBITDA due to elevated sales and marketing expenses aimed at boosting new customer growth. The call also highlighted a 9% revenue increase to $49.8 million in Q4 2024, with a 71.8% gross profit margin, up 247 basis points year-over-year, and an adjusted EBITDA margin of 30.3%. The company ended fiscal year 2024 with cash and cash equivalents of $39.3 million.Revenue Growth
Fourth quarter revenue was $49.8 million, up 9% from the prior year period. Procedure revenue growth increased 5%, and dietary supplement revenue increased 10.2% year-over-year.
Gross Profit Margin Improvement
Fourth quarter gross profit margin was 71.8%, a 247 basis point increase from the fourth quarter of 2023, reflecting cost savings from vertical integration and effective cost management.
Adjusted EBITDA Growth
Adjusted EBITDA increased 11.4% to $15.1 million, with an adjusted EBITDA margin of 30.3%, reflecting the operating leverage of the business model.
Successful Acquisition Integration
The acquisition of Asteria Health strengthened control over the supply chain, improved product quality, and generated cost efficiencies by vertically integrating internal manufacturing.
Introduction of BioteRx Platform
The phased launch of BioteRx wellness platform is a key competitive differentiator, providing practitioners with a seamless platform for product ordering, inventory management, and technical support.
---
BTMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
BTMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 12, 2025 | $4.10 | $3.07 | -25.12% |
| Nov 12, 2024 | $5.52 | $6.72 | +21.74% |
| Aug 08, 2024 | $6.77 | $5.49 | -18.91% |
| May 07, 2024 | $5.77 | $6.07 | +5.20% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does biote (BTMD) report earnings?
biote (BTMD) is schdueled to report earning on May 13, 2025, TBA Not Confirmed.
What is biote (BTMD) earnings time?
biote (BTMD) earnings time is at May 13, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BTMD EPS forecast?
BTMD EPS forecast for the fiscal quarter 2025 (Q1) is 0.08.
---